mRNA |
Tipifarnib |
FIMM |
pan-cancer |
AAC |
-0.3 |
0.02 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.02 |
mRNA |
AT-406 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.02 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.12 |
0.02 |
mRNA |
StemRegenin 1 |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.02 |
mRNA |
BRD1812 |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.02 |
mRNA |
Irinotecan |
gCSI |
pan-cancer |
AAC |
-0.12 |
0.03 |
mRNA |
dexamethasone |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.03 |
mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.03 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.03 |